Technical Specifications Compound: Glycyl-L-Histidyl-L-Lysine Copper Complex (GHK-Cu) Format: Lyophilized peptide Strength: 50 mg per vial Purity: 9899% (COA included) Appearance: Blue-hued lyophilized powder Category: Research reagent (non-clinical) Intended Use This product is intended exclusively for: Laboratory research In-vitro experimentation Biochemical and molecular assays Mechanistic pathway studies Preclinical, non-human model exploration Institutional or academic research programs Not intended for: Human or veterinary consumption Cosmetic or dermatological use Injection, ingestion, inhalation, or topical use Medical, therapeutic, or clinical applications This material is not approved by Health Canada, FDA, or any regulatory authority for clinical use

Common Semaglutide Compounded Formulations Compounded semaglutide is often marketed under names that mimic brand drugs, such as semaglutide with B12 or semaglutide sodium. These compounded formulations are not FDA-approved, and many lack safety testing and quality control
This helps trigger insulin production, regulate blood sugar, and manage appetite
Similar content being viewed by others Subjects Introduction Obesity is a major public health concern with the prevalence remaining high globally, bringing healthcare challenges across countries [1, 2]